+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Global Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs: Global Strategic Business Report - Product Thumbnail Image

Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs: Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 323 Pages
  • Global
From
Asthma And COPD Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Asthma And COPD Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • November 2021
  • 101 Pages
  • Global
From
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Global Market Report 2024 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2023 to 2027 - Product Thumbnail Image

Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2023 to 2027

  • Report
  • April 2024
  • 449 Pages
  • Global
From
Global Antibiotics Market - Distribution by Type of Drug Class, Target Disease Indication, Type of Therapy (Monotherapies and Combination Therapies), Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Global Antibiotics Market - Distribution by Type of Drug Class, Target Disease Indication, Type of Therapy (Monotherapies and Combination Therapies), Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • April 2023
  • 175 Pages
  • Global
From
Global Antibiotic Resistance Market Size, Share & Trends Analysis Report by Disease (cUTI, CDI), Pathogen, Drug Class, Mechanism of Action, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Global Antibiotic Resistance Market Size, Share & Trends Analysis Report by Disease (cUTI, CDI), Pathogen, Drug Class, Mechanism of Action, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Global Peptide Antibiotics Market Size, Share & Trends Analysis Report by Product Type, by Disease, by Route Of Administration (Oral, Injectable, Topical), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Global Peptide Antibiotics Market Size, Share & Trends Analysis Report by Product Type, by Disease, by Route Of Administration (Oral, Injectable, Topical), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030

  • Report
  • July 2022
  • 150 Pages
  • Global
From
Global Peptide Antibiotics Market by Type (Non-Ribosomal Synthesized Peptide Antibiotics, Ribosomal Synthesized Peptide Antibiotics), Disease (Blood Stream Infections, HABP/VABP, Skin Infections), Route of Administration, Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Peptide Antibiotics Market by Type (Non-Ribosomal Synthesized Peptide Antibiotics, Ribosomal Synthesized Peptide Antibiotics), Disease (Blood Stream Infections, HABP/VABP, Skin Infections), Route of Administration, Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 186 Pages
  • Global
From
Global Methicillin-Resistant Staphylococcus Aureus Drugs Market by Agent Type (Ceftaroline, Daptomycin, Linezolid), Route of Administration (Oral, Parenteral), Sales Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Methicillin-Resistant Staphylococcus Aureus Drugs Market by Agent Type (Ceftaroline, Daptomycin, Linezolid), Route of Administration (Oral, Parenteral), Sales Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 199 Pages
  • Global
From
Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 325 Pages
  • Global
From
Antibiotic Resistance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Antibiotic Resistance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 111 Pages
  • Global
From
Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 714 Pages
  • Global
From
Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 122 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 632 Pages
  • Global
From
Antibiotic Resistance Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Antibiotic Resistance Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • October 2023
  • 150 Pages
  • Global
From
Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Glycopeptide Antibiotics Global Market Report 2024 - Product Thumbnail Image

Glycopeptide Antibiotics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Peptide Antibiotics Global Market Report 2024 - Product Thumbnail Image

Peptide Antibiotics Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Loading Indicator